Singapore National Eye Centre will NEVER ask you to transfer money over a call. If in doubt, call the 24/7 ScamShield helpline at 1799, or visit the ScamShield website at www.scamshield.gov.sg.

Cataract & Comprehensive Ophthalmology

Synonym(s):

The Cataract & Comprehensive Ophthalmology Department is dedicated to delivering quality general eye care and specialised cataract services. Led by Dr Melissa Wong, Head and Senior Consultant, our department is supported by more than 80 ophthalmologists. The department forms the backbone of primary eye care for most patients.


Our care services:

General eye care services:
- Comprehensive evaluation and treatment for cataracts
- Eye assessments and management for sight-threatening eye diseases such as glaucoma, diabetic retinopathy and age-related macular degeneration 

Other services:
- Assessment and management of floaters, flashes, dry eyes, eye infections,
- Various retinal conditions such as corneal and ocular surface disorders, eyelid diseases like ptosis-eye injuries 

A wide range of diagnostic and screening services are available, including refraction and optometric services, slit-lamp evaluation, ophthalmoscopy, tonometry, gonioscopy, retina and optic nerve scanning and visual field testing. The department also provides referrals for and coordinates advanced care in subspecialty departments within SNEC.


Why Choose SNEC?

Quality Assurance

  • 90% of surgeries conducted in SNEC are cataract surgeries. SNEC performs more than 21,000 cataract surgeries annually with a success rate of 98% to 99%. These take place both at the main centre and at satellite branches. The overall visual success rate is very high at 98% to 99% (patients achieve best-corrected visual acuity [BCVA] of 6/12 or better). 13,919 of the 17,682 cataract surgeries performed in 2014 at SNEC were performed at SNEC's main centre with the remainder carried out at its branches.The average endophthalmitis (sight-threatening microbial infection) incidence rate was very low for the 127,046 cataract operations performed from 2005 to 2014 at 0.0143% for culture-positive and 0.0208% for cases diagnosed using clinical criteria.       

Access to Advanced Lens Technology:

  • Intraocular lens research has advanced rapidly over the past decade — from early monofocal lenses to multifocal and extended depth of focus lenses, beyond standard options, SNEC offers improved intermediate vision with fewer visual disturbances. SNEC-SERI is also actively involved in advanced intraocular lens (IOL) research, focusing on developing novel IOL designs to improve vision for patients, particularly those with complex eye conditions.

Training the Experts:

  • SNEC organises the renowned cataract surgery teaching courses for local and overseas eye doctors, such as the well-received annual Basic and Advanced Ophthalmic Microsurgical Workshop and train, as well as trains international fellows from countries like China, the Philippines and Indonesia, etc.  

87
ophthalmologists

 

> 136,300
outpatient visits a year

 

> 99%
overall visual success rate (6/12 or better)

 

“Our department strives to achieve excellent results and maintain high quality care. We have the highest cataract surgical volume in Singapore and this reflects the trust that patients have in us. We will continue to upkeep these standards.”

Dr Melissa Wong

Head and Senior Consultant

Cataract and Comprehensive Ophthalmology Department

Our Care Team

News

Research Formosa Pharmaceuticals and SERI Partner to Advance Novel Ophthalmic Formulations for Corneal Diseases SINGAPORE / TAIPEI — April 30, 2026 – Formosa Pharmaceuticals, Inc. (“Formosa”, 6838.TW) and the Singapore Eye Research Institute (“SERI”) are pleased to announce a strategic research collaboration to develop next-generation ophthalmic formulations. This partnership will leverage Formosa’s proprietary APNT® (Active Pharmaceutical (ingredient) Nanoparticle Technology) and SERI’s world-class clinical research expertise, led by renowned Clinician Scientist, Associate Professor Yu-Chi Liu, MD, PhD. The collaboration aims to address significant unmet needs in the treatment of corneal and ocular surface diseases. By combining innovative and clinically validated drug delivery platforms with deep clinical insights, the joint effort seeks to enhance the efficacy, bioavailability, and safety of topical ocular therapies, bringing new therapies to clinical practice. Synergy of Innovation and Clinical Excellence A/Prof Yu-Chi Liu, clinician scientist at Singapore National Eye Center and Principal Investigator at SERI, brings extensive experience in corneal neuropathy and translational medicine to the collaboration. Her recent work in diabetic keratopathy and ocular surface inflammation will be pivotal in guiding the development of formulations targeting complex anterior segment conditions. "Collaborating with Formosa Pharmaceuticals allows us to bridge the gap between benchside innovation and bedside application," said A/Prof. Yu-Chi Liu. "Our goal is to utilize advanced formulation technologies like APNT to create treatments that are not only more effective but also less burdensome for patients suffering from ocular conditions." Leveraging APNT® Technology Formosa Pharmaceuticals’ APNT® platform specializes in reducing the particle size of active pharmaceutical ingredients (APIs) to stable, uniform nanoparticles. This technology is a hallmark of Formosa's development pipeline, offering a powerful solution for improving the delivery of poorly soluble drugs to the target tissues and organs. "We are honored to work alongside Professor Liu and her distinguished team at SERI," said Erick Co, President & CEO of Formosa Pharmaceuticals. "Initial efforts have confirmed compatibility of APNT and SERI’s research models and prompt us to extend our partnership. SERI’s reputation for excellence in vision research, backed by their comprehensive capabilities and facilities, are unparalleled. Together, we are excited to translate the research findings into better clinical outcomes."
30 Apr 2026 Read Story
Education Singapore National Eye Centre and Singapore Polytechnic collaborate to strengthen optometrists’ role in community eye care The partnership will see both parties co-develop the Clinical Decision-Making in Community Optometry training programme for practicing community optometrists to build on their competencies to deliver quality eye care in the community.
05 Mar 2026 Read Story